Showing results (1821-1830 of 2,073) with videos related to
Sort By:
Pageof 208
Pediatric Diabetes|June 30, 2021
Risky sexual behaviors in adolescents and young adult women with type 1 diabetes: An overlooked problemFranco Giraudo, Ignacio Lalanne, Ismael Valdés, et al.Pediatric Diabetes|May 13, 2022
Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registrySteven James, Lin Perry, Julia Lowe, et al.Pediatric Diabetes|May 13, 2022
Parents' views about healthcare professionals having real-time remote access to their young child's diabetes data: Qualitative studyBarbara Kimbell, David Rankin, Ruth I Hart, et al.Pediatric Diabetes|June 3, 2022
Sulfonylurea for improving neurological features in neonatal diabetes: A systematic review and meta-analysesCaroline de Gouveia Buff Passone, Elisa Giani, Laurence Vaivre-Douret, et al.Pediatric Diabetes|June 1, 2022
Hospitalization and comorbidity in children with type 2 diabetesElizabeth A C Sellers, Lorraine McLeod, Heather J Prior, et al.Pediatric Diabetes|February 1, 2018
Higher body mass index predicts cardiac autonomic dysfunction: A longitudinal study in adolescent type 1 diabetesYoon H Cho, Maria E Craig, Tracey Jopling, et al.Pediatric Diabetes|January 10, 2018
Incidence of childhood onset type 1 diabetes in Western Australia from 1985 to 2016: Evidence for a plateauAveni Haynes, Max K Bulsara, Timothy W Jones, et al.Pediatric Diabetes|December 18, 2018
An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetesKerry Buchanan, Ahmed M Mehdi, Ian Hughes, et al.Pediatric Diabetes|December 22, 2018
Earlier puberty in boys with type 1 diabetes mellitus compared to a simultaneously recruited group of control adolescentsXimena Gaete, Maritza Vivanco, Patricia Lopez, et al.Pediatric Diabetes|February 24, 2018
Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokineticsGordon C Weir, Mario R Ehlers, Kristina M Harris, et al.Pageof 208